Maytê Santos Toledo

Dr. Maytê Santos Toledo


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 June 2024 in Genes
Verified
Journal Article
Open access
PDF file
VTVanessa Romanelli Tavares
Vanessa Romanelli Tavares
RMRodrigo Holanda Mendonça
Rodrigo Holanda Mendonça
MTMaytê Santos Toledo
Maytê Santos Toledo
SHSônia M. Hadachi
Sônia M. Hadachi
CGCarmela M. Grindler
Carmela M. Grindler
MFMarcondes C. França
Marcondes C. França
In recent years, significant progress has been made in 5q Spinal Muscular Atrophy therapeutics, emphasizing the importance of early diagnosis and intervention for better clinical outcomes. Characterized by spinal cord motor neuron degeneration, 5q-SMA leads to muscle weakness, swallowing difficulties, respiratory insufficiency, and skeletal deformities. Recognizing the pre-symptomatic phases supported by screening and confirmatory genetic tests is crucial for early diagnosis. This work addresses key considerations in implementing 5q-SMA screening within the Brazilian National Newborn Screening Program and explores Brazil’s unique challenges and opportunities, including genetic tests, time-to-patient referral to specialized centers, program follow-up, and treatment algorithms. We aim to guide healthcare professionals and policymakers, facilitating global discussions, including Latin American countries, and knowledge-sharing on this critical subject to improve the care for newborns identified with 5q SMA.